Recently, the Clinical Laboratory Center (NCCL) of the National Health Commission announced the results of the national clinical laboratory quality evaluation in 2019. All the 28 projects participated by Baibo Biology passed the evaluation and obtained qualification certificates. The project covers 20 routine chemistry items, 1 cysteine protease inhibitor, 1 myocardial marker, and 6 lipids.
Inter-office quality evaluation is an important part of the internationally recognized clinical laboratory's total quality management and an important part of the quality management of medical institutions. The results of the National Health Commission’s external quality assessment have witnessed Jinan Biobio’s efforts in the field of in vitro diagnostics in the past year, and also demonstrated the excellent quality of Biobio’s products, accurate and reliable test results, and users’ trust. BioBio will continue to strictly control every quality link, improve product quality, and provide more reliable medical diagnostic products for clinics.
